MX2021015289A - Metiltioninio como mejorador de la funcion cognitiva. - Google Patents

Metiltioninio como mejorador de la funcion cognitiva.

Info

Publication number
MX2021015289A
MX2021015289A MX2021015289A MX2021015289A MX2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A
Authority
MX
Mexico
Prior art keywords
methylthioninium
enhancers
cognitive function
demented
leuco
Prior art date
Application number
MX2021015289A
Other languages
English (en)
Inventor
Charles Robert Harrington
Claude Michel Wischik
Gernot Riedel
Jochen Klein
Karima Schwab
Original Assignee
Wista Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Lab Ltd filed Critical Wista Lab Ltd
Publication of MX2021015289A publication Critical patent/MX2021015289A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/34—Coverings or external coatings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2203/00—Decoration means, markings, information elements, contents indicators
    • B65D2203/02—Labels

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere en general, a composiciones nootrópicas que comprenden sales de ácido leuco-metiltioninio y sus usos para el mejoramiento cognitivo en individuos normales (no dementes).
MX2021015289A 2019-07-01 2020-06-29 Metiltioninio como mejorador de la funcion cognitiva. MX2021015289A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1909454.9A GB201909454D0 (en) 2019-07-01 2019-07-01 Enhancers
PCT/EP2020/068229 WO2021001306A1 (en) 2019-07-01 2020-06-29 Methylthioninium as enhancers of the cognitive function

Publications (1)

Publication Number Publication Date
MX2021015289A true MX2021015289A (es) 2022-01-18

Family

ID=67539959

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015289A MX2021015289A (es) 2019-07-01 2020-06-29 Metiltioninio como mejorador de la funcion cognitiva.

Country Status (12)

Country Link
US (1) US20220330594A1 (es)
EP (1) EP3989977A1 (es)
JP (1) JP2022539185A (es)
KR (1) KR20220028045A (es)
CN (1) CN114096254A (es)
AU (1) AU2020298737A1 (es)
BR (1) BR112021025330A2 (es)
CA (1) CA3143417A1 (es)
GB (1) GB201909454D0 (es)
IL (1) IL289341A (es)
MX (1) MX2021015289A (es)
WO (1) WO2021001306A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2912571T3 (es) 2006-07-11 2022-05-26 Wista Lab Ltd Procedimientos de síntesis y/o de purificación de compuestos de diaminofenotiazinio

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
PT2013191E (pt) 2006-03-29 2010-10-29 Wista Lab Ltd Sais de 3,7-diamino-10h-fenotiazina e a sua utilização
PT2167095T (pt) 2007-06-19 2019-08-06 Wista Lab Ltd Compostos de fenotiazina para o tratamento de comprometimento cognitivo leve
PL2205245T3 (pl) 2007-10-03 2015-12-31 Wista Lab Ltd Zastosowanie terapeutyczne diaminofenotiazyn
US9283230B2 (en) 2011-02-11 2016-03-15 Wista Laboratories Ltd. Phenothiazine diaminium salts and their use
EP2705841A1 (en) 2012-09-05 2014-03-12 Pharnext Combinations of nootropic agents for treating cognitive dysfunctions
KR102475825B1 (ko) 2016-07-25 2022-12-08 위스타 레보레이토리스 리미티드 디아미노페노티아진 (diaminophenothiazines)의 투여 및 투여량 (dosage)
GB201614834D0 (en) 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia

Also Published As

Publication number Publication date
JP2022539185A (ja) 2022-09-07
KR20220028045A (ko) 2022-03-08
AU2020298737A1 (en) 2022-02-24
CN114096254A (zh) 2022-02-25
US20220330594A1 (en) 2022-10-20
EP3989977A1 (en) 2022-05-04
IL289341A (en) 2022-02-01
BR112021025330A2 (pt) 2022-02-01
CA3143417A1 (en) 2021-01-07
GB201909454D0 (en) 2019-08-14
WO2021001306A1 (en) 2021-01-07

Similar Documents

Publication Publication Date Title
MX2022000711A (es) Inhibidores de parp1.
MA46990B1 (fr) Compositions glp-1 et ses utilisations
MA50817B1 (fr) Formes et formulations solides de (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
MX343346B (es) Composición tipo azeotropo de hexafluoropropano, hexafluoropropeno y fluoruro de hidrógeno.
MY161390A (en) Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
EA201591379A1 (ru) Липопротеин-ассоциированные ингибиторы фосфолипазы a2 (lp-pla) на основе 2,3-дигидроимидазо[1,2-с]пиримидин-5(1h)-онов
MX2020001885A (es) Formulaciones de daptomicina.
AU2020258568A8 (en) CD73 inhibitors
EA201991532A1 (ru) Применение хелатирующих агентов для улучшения стабильности цвета резорцинола
BR112018009609A2 (pt) composições dentifrícias com absorção melhorada de fluoreto
MX2021000759A (es) Derivados de triazolquinoxalina adicionalmente sustituidos.
NZ708648A (en) Learning and memory improver
MX2020006355A (es) Pirrolidinamidas ii sustituidas.
MX2021000762A (es) Derivados de triazoloquinoxalina sustituida.
EA202192288A1 (ru) Соединения на основе нейрегулина-4 и способы их применения
BR112022008183A2 (pt) Formas de sal de um receptor de c5a de componente do complemento
MX2021015289A (es) Metiltioninio como mejorador de la funcion cognitiva.
MX2023002113A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
UA113540C2 (xx) Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду
WO2020123816A3 (en) Anellosomes and methods of use
EA202090470A1 (ru) Композиция для личного ухода
EA202191446A1 (ru) Композиции для улучшения сексуальной функции
WO2021041324A3 (en) Compositions and methods for the treatment of pathological pain and itch
ES2514140A1 (es) Uso del inhibidor de sulfatasas esteroideas STX64 para el tratamiento del envejecimiento